Project Grant R01EY036011
Award Date
7/1/24
Completion Date
5/31/29
Dollars Obligated
$390K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The National Eye Institute (NEI) awarded a $244,015 Project Grant (CFDA 93.867 - Vision Research) to The Research Foundation For The State University Of New York (Upstate Medical Center) to develop a novel "TM/SC-Interface-On-A-Chip" microfluidic platform to investigate dynamic regulation of aqueous humor outflow and its role in glaucoma pathogenesis. The key products and services to be delivered under this grant include: Design and validation of a microfluidic chip-based model that...
This $661,635 federal Project Grant, awarded by the National Eye Institute (NIE) under the Vision Research program (CFDA 93.867), aims to elucidate the molecular changes in the extracellular matrix (ECM) of the conventional outflow pathway that regulate outflow facility in steroid-induced ocular hypertension and open-angle glaucoma. The research will employ a biomimetic artificial conventional outflow system (ACOS) to identify ECM differences between healthy and steroid-treated human...
The National Eye Institute (NEI) awarded a $409,375 Project Grant under the Vision Research program (CFDA 93.867) to The Johns Hopkins University to study the biomechanics of the human optic nerve head for developing glaucoma biomarkers. The 5-year project, running from July 2024 to June 2029, will use optical imaging and finite element modeling to analyze optic nerve head deformations and mechanical properties in patients with primary open-angle glaucoma. The goal is to identify biomechanical...
This $447,479 Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research by Georgia Tech Research Corp to decipher the molecular mechanisms underlying the pathophysiology of trabecular meshwork (TM) cell loss in glaucoma. The project aims to use a yeast model system to screen for genetic and small molecule modulators that can rescue the cytotoxicity caused by the misfolding of the myocilin protein, which is strongly linked to an...
The National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) awarded a $1,066,178 Project Grant to Tavo Biotherapeutics, Inc. (operating as Oculo Therapy LLC), a woman-owned small business, to support the late-stage preclinical development and GMP production of a first-in-class extended-release intraocular pressure (IOP)-lowering formulation for the treatment of glaucoma. The grant funds research and development activities focused on optimizing a novel, topical,...
This $185,000 Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to discover novel disease-modifying therapies for the prevention and treatment of glaucoma. The principal investigators, Dr. Abbot F. Clark and Dr. David P. Siderovski from the University of North Texas Health Science Center (UNTHSC), will use computational and experimental approaches to identify small molecule inhibitors that can interfere with the...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to optimize lead compounds, determine their mechanism of action, and provide additional data to support their development as topically administered therapeutics for the treatment of primary open-angle glaucoma (POAG) and steroid-induced glaucoma. The $617,323 award, effective from July 1, 2024 to June 30, 2028, will enable the University of Notre Dame DU Lac to conduct...
This federal Project Grant award in the amount of $230,430.00 was provided by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to the University of Maryland, Baltimore. The grant will support a two-year research project titled "Development of Robust Corneal Biomechanical Biomarkers for Glaucoma Using Brillouin Microscopy". The project aims to compare corneal biomechanical properties between primary open-angle glaucoma patients and healthy controls...
The National Eye Institute (NEI) awarded a $387,428 Project Grant (CFDA 93.867 Vision Research) to The Research Foundation For The State University Of New York, operating as Upstate Medical Center, to investigate mechanisms that drive optic nerve sensitivity to elevated intraocular pressure in glaucoma. The research aims to: 1) Determine how optic nerve head astrocytes integrate transient biomechanical strains to predispose to future glaucomatous dysfunction; 2) Explore the link between...
The National Eye Institute (NEI) awarded a $251,295 Project Grant (CFDA 93.867 - Vision Research) to The Research Foundation for the State University of New York, doing business as Upstate Medical Center, to establish an in vitro 3D culture system to study the cellular interactions and fibrotic signaling pathways between optic nerve head (ONH) astrocytes and lamina cribrosa (LC) cells in response to mechanical strain. The project aims to investigate the role of the fibronectin extra domain...